DALBEN 1,9
ALBENDAZOLE
About this veterinary medicine
DALBEN 1,9 is a veterinary medicine in the form of suspension buvable containing albendazole. It is marketed by CEVA S.A. TUNISIE. It holds a marketing authorisation in Tunisia under number 144.540.96.
Characteristics
- Form
- suspension buvable
- Strength
- 1.900%
- Presentation
- Bidon de 5 litres
- Route of administration
- Oral route
- Laboratory
- CEVA S.A. TUNISIE
- Country
- TUNISIE
Regulatory status — Tunisie
🟢 Marketing authorisation in force
Authorisation no. : 144.540.96 — Authorisation date : 12/04/1996
⚠️ Regulatory alerts
No alert reported.
🔴 Batch recalls
No batch currently reported as recalled.
📦 Availability in Tunisia
Reported by TunisieVet veterinarians.
No availability information yet.
🔒 Availability reporting is reserved for signed-in veterinarians.
Sources
- dpm verified on 30/09/2026
Last synchronisation : 30/09/2026
Report availability
Sign in to your veterinarian account to report availability.
Log InOnly veterinarians can report availability.
TunisieVet in your pocket 📱🐾 Access your veterinary services wherever you are. [ Download the app ]
Learn more